$1.41
CEL-SCI is a biotechnology business based in the US. CEL-SCI shares (CVM) are listed on the NYSE MKT and all prices are listed in US Dollars.
Our top picks for where to buy CEL-SCI stock
How to buy CEL-SCI stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CVM. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy CEL-SCI stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
CEL-SCI stock price (NYSE MKT: CVM)
Use our graph to track the performance of CVM stocks over time.CEL-SCI shares at a glance
Latest market close | $1.41 |
---|---|
52-week range | $1.04 - $3.23 |
50-day moving average | $1.26 |
200-day moving average | $1.94 |
Wall St. target price | $7.73 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.63 |
Is it a good time to buy CEL-SCI stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
CEL-SCI price performance over time
Historical closes compared with the close of $1.41 from 2024-07-22
1 week (2024-07-16) | -6.00% |
---|---|
1 month (2024-06-21) | 9.30% |
3 months (2024-04-23) | -4.08% |
6 months (2024-01-23) | -46.79% |
1 year (2023-07-21) | -28.43% |
---|---|
2 years (2022-07-22) | -63.09% |
3 years (2021-07-23) | 7.68 |
5 years (2019-07-23) | 6.17 |
CEL-SCI financials
Revenue TTM | $28,558 |
---|---|
Gross profit TTM | $-25,355,346 |
Return on assets TTM | -53.51% |
Return on equity TTM | -173.88% |
Profit margin | 0% |
Book value | $0.26 |
Market Capitalization | $71.5 million |
TTM: trailing 12 months
CEL-SCI share dividends
We're not expecting CEL-SCI to pay a dividend over the next 12 months.
Have CEL-SCI's shares ever split?
CEL-SCI's shares were split on a 1:25 basis on 14 June 2017. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your CEL-SCI shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for CEL-SCI shares which in turn could have impacted CEL-SCI's share price.
CEL-SCI share price volatility
Over the last 12 months, CEL-SCI's shares have ranged in value from as little as $1.04 up to $3.23. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while CEL-SCI's is 0.667. This would suggest that CEL-SCI's shares are less volatile than average (for this exchange).
CEL-SCI overview
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development of immune system therapy for the treatment of cancer and other diseases in the United States. The company's lead immunotherapy is Multikine, which has completed Phase 3 clinical trials for the potential treatment of certain head and neck cancers. It is also developing products based on its proprietary technology Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer. In addition, the company's product pipeline includes CEL-2000; CEL-4000; and CEL-5000, which are LEAPS-based product candidates in preclinical trials for the treatment of rheumatoid arthritis disease. CEL-SCI Corporation was incorporated in 1983 and is headquartered in Vienna, Virginia. .
Frequently asked questions
nullWhat percentage of CEL-SCI is owned by insiders or institutions?
Currently 3.314% of CEL-SCI shares are held by insiders and 14.289% by institutions. When does the fiscal year end for CEL-SCI?
CEL-SCI's fiscal year ends in September. Where is CEL-SCI based?
CEL-SCI's address is: 8229 Boone Boulevard, Vienna, VA, United States, 22182 What is CEL-SCI's ISIN number?
CEL-SCI's international securities identification number is: US1508376076 What is CEL-SCI's CUSIP number?
CEL-SCI's Committee on Uniform Securities Identification Procedures number is: 150837409
More guides on Finder
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Frec review 2024: Low-cost direct indexing and individual stock trading
A deep dive into the highlights and limitations of Frec.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
5 top graphene stocks to invest in today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question